Reactive Biosciences Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $4M

  • Investors
  • 15

Reactive Biosciences General Information

Description

Developer of a novel synthetic chemistry platform designed to provide pharmacophores and drug modalities to address unmet therapeutic needs. The company's platform supports sustainable farming methods by creating a compound that decreases the probability of fungicide resistance and reduces the number of chemicals applied while maintaining performance and efficacy, enabling healthcare professionals to address unmet needs and challenges across multiple sectors.

Contact Information

Formerly Known As
Boragen
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • PO Box 110087
  • Durham, NC 27709
  • United States
+1 (919)
Primary Industry
Drug Discovery
Other Industries
Agricultural Chemicals
Corporate Office
  • PO Box 110087
  • Durham, NC 27709
  • United States
+1 (919)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Reactive Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 22-Jun-2023 $4M Completed Generating Revenue
7. Later Stage VC 12-Sep-2022 Completed Generating Revenue
6. Grant 21-Jul-2020 Completed Generating Revenue
5. Grant 08-Jul-2020 Completed Generating Revenue
4. Later Stage VC (Series A1) 15-May-2020 Completed Generating Revenue
3. Early Stage VC (Series A) 22-Mar-2017 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2017 Completed Generating Revenue
1. University Spin-Out 01-Jan-2015 Completed Startup
To view Reactive Biosciences’s complete valuation and funding history, request access »

Reactive Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
To view Reactive Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Reactive Biosciences Patents

Reactive Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025007074-A1 Chemical compounds Inactive 30-Jun-2023
WO-2024192309-A1 Chemical compounds Inactive 15-Mar-2023
WO-2021061823-A1 Chemical compounds Inactive 23-Sep-2019
WO-2021021932-A1 Flow reaction process for manufacture of boron-containing agrochemicals Inactive 30-Jul-2019
WO-2021003501-A1 Chemical compounds Inactive 03-Jul-2019 C07F5/025
To view Reactive Biosciences’s complete patent history, request access »

Reactive Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Reactive Biosciences Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Canaan Partners Venture Capital Minority
National Institute Of Allergy and Infectious Diseases Government
Invent Penn State Accelerator/Incubator Minority
Alexandria Venture Investments Venture Capital Minority
ARCH Venture Partners Venture Capital Minority
You’re viewing 5 of 15 investors. Get the full list »

Reactive Biosciences FAQs

  • When was Reactive Biosciences founded?

    Reactive Biosciences was founded in 2015.

  • Where is Reactive Biosciences headquartered?

    Reactive Biosciences is headquartered in Durham, NC.

  • What is the size of Reactive Biosciences?

    Reactive Biosciences has 4 total employees.

  • What industry is Reactive Biosciences in?

    Reactive Biosciences’s primary industry is Drug Discovery.

  • Is Reactive Biosciences a private or public company?

    Reactive Biosciences is a Private company.

  • What is Reactive Biosciences’s current revenue?

    The current revenue for Reactive Biosciences is .

  • How much funding has Reactive Biosciences raised over time?

    Reactive Biosciences has raised $45M.

  • Who are Reactive Biosciences’s investors?

    Canaan Partners, National Institute Of Allergy and Infectious Diseases, Invent Penn State, Alexandria Venture Investments, and ARCH Venture Partners are 5 of 15 investors who have invested in Reactive Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process